Skip to content
Study details
Enrolling now

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

AIDS Malignancy Consortium
NCT IDNCT04949464ClinicalTrials.gov data as of Apr 2026
Target enrollment

100

Study length

about 3.8 years

Ages

45–80

Locations

11 sites in CA, DC, FL +6

About this study

Researchers are testing if a smartphone-based smoking cessation intervention, used at the time of lung cancer screening, can help people living with HIV quit smoking. The trial will last for 1375 days and aims to enroll approximately 100 participants.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Smoking Cessation Intervention
  • 2.Undergo Computed Tomography
Primary goalNumber of participants who complete the low dose chest CT scan within 60 days of enrollment

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low8%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Number of participants who complete the low dose chest CT scan within 60 days of enrollment

Secondary: Number of participants reporting anxiety related symptoms (concentration problems, memory problems, insomnia and anxiety) on the NCI PROCTCAE

Procedures

imaging

Body systems

Oncology, Immune, Infectious